SlideShare a Scribd company logo
1 of 62
Ryan J. Tedford, MD, FACC, FAHA, FHFSA
Peter C. Gazes Endowed Chair and Professor of Medicine
Section Chief, Heart Failure
Medical Director, Cardiac Transplant
Medical University of South Carolina, Charleston, SC
Hemodynamic Evaluation of Pulmonary
Hypertension— Principles and Best Practices
13TH ANNUAL NORTH CAROLINA RESEARCH TRIANGLE
PULMONARY HYPERTENSION SYMPOSIUM
November 5, 2021
@RyanTedfordMD
Disclosures
Medtronic/Accerelon –Steering Committees
Actelion/Merck – Hemodynamic Core Lab
Abiomed – Research Advisory Group
Consultant –United Therapeutics, Medtronic, Aria CV, Gradient,
Itamar, Edward LifeSciences, Eidos Therapeutics, Lexicon, CareDx
I Love Right Heart Catheterizations and Hemodynamics!
Ryan J. Tedford, MD
Objectives
1. Review best practices of the right heart
catheterization
2. Detail waveform interpretation including
considerations of how to accurately measure the
PAWP
3. Appraise importance of RHC timing and provocative
challenges in the diagnosis of PH
Two Basic and Critical Principles
1. Always perform a right heart catheterization BEFORE
starting any PAH specific therapy
2. PAH specific therapy is not recommended in LHD
2015 ERS/ESC PH
guidelines
Case
35 year old woman with IPAH, previously vasoreactive
(treated with calcium channel blocker therapy)
› Lost vasoreactivity – treated with riocuiguat and ambrisentan
› Progressive symptoms – near syncope and volume overload
› Referred for RHC prior to planned initiation of IV epoprostenol
RHC
SBP 96/70, HR 98
RA 9, RV 130/20, PA 130/60 (90), W 40
CO/CI - 4.5/2.6 (TD)
Nitroprusside – PA 115/61 (81), no PAWP or CO/CI recorded
Sent back to MICU
Phone call: What to do with the PAWP of 40mmHg? Should we start
epoprostenol or not?
Before you begin
Know what to expect
Get comfortable (you and the patient)!
Patient positioning
› Patient is supine with legs flat
› Right internal jugular access (or antecubital) unless contraindication
› No sedation is preferable; if absolutely necessary, premedication with oral
medication much preferred over IV administration
Before you begin
› Level the transducer in a supine
patient :
› Left atrium: Mid chest is halfway
between the anterior sternum and
the bed surface.
› Measure it!
› Zero the transducer
Kovacs g. Eur Respir J. 2013 Dec;42(6):1586-94.
*J Am Coll Cardiol. 2013;62(25_S)
General Principles –
RHC measurements
All pressure tracings must be accompanied by a simultaneous ECG tracing (directly
above or below the pressure tracing) which is used for timing and analysis of waveforms.
If PVC’s are present, the tracings should be re-recorded unless PVC burden is too high
to allow for a PVC-free recording.
All hemodynamic recordings should be taken while patient is breathing quietly and
spontaneously. No breath hold maneuvers should be used.1
Do not record any data while the patient is restless, talking, or coughing.
1Hoeper MM et al. Definitions and Diagnosis of PH.
J Am Coll Cardiol 2013;62:D42–50
Examining The Tracing Quality
If pressure tracings appear dampened (for example, no dichotic notch is seen on the PA
pressure tracing), re-flush the catheter and tubing to insure there are no air bubbles in
either.
Watson CA et al. Anaesthesia and Intensive Care Medicine (13), 2012, 116-120.
Maron BA…Tedford RJ. JACC 2020 Dec 1.
Examining The Tracing Quality
If catheter ringing is present, try flushing all tubing first, and if not successful,
introducing a small amount of blood back into the catheter may be helpful (to
change the resonant frequency) – must be careful to overdamp the signal.
Watson CA et al. Anaesthesia and Intensive Care Medicine (13), 2012, 116-120.
Maron BA…Tedford RJ. JACC 2020 Dec 1.
Dealing with Catheter Ringing
Lim MJ. Hemodynamic Rounds, 3rd edition, 2009
Maron BA…Tedford RJ. JACC 2020 Dec 1.
PAWP is the sole discriminator of PH – critical
to get it right
Maron BA…Tedford RJ. JACC 2020 Dec 1.
Key issues with PAWP measurement
How to measure the PAWP at rest?
› What is normal (<=15mmHg)?
› Where in the cardiac cycle?
› Where in the respiratory cycle?
What is the normal value of PAWP ?
1958 – The left atrial pressure averaged 2-3 mmHg 1
1975 – The « capillary » pressure is in the order of 6-9 mmHg
and may even reach 12 mmHg; …seems little affected by age.
It gives a good indication of the mean LAP provided that it does
not exceed 25 mmHg 2
2002 – The inclusion criteria were… a pulmonary capillary
wedge pressure < 15 mmHg, and PVR > 240 dyn·sec·cm-5
2007 – mean PAWP > 12 mmHg or LVEDP > 16 mmHg 4
2016 – PAWP ≥ 15 mmHg or LVEDP ≥16 mmHg 5
1. Wood P. Br Heart J. 1958;20:557-70. 2. Proceedings of the WHO
Symposium 1975. 3. Rubin LJ et al. N Engl J Med. 2002; 346:896-
903. 4. Paulus W et al. European Heart Journal (2007) 28, 2539–
2550. 5. Ponikowski P et al. Eur Heart J 2016; 37, 2129–2200
What is the normal PAWP?
The “normal PAWP” has creeped up over time
Many early studies considered a “normal PAWP” < 12
mmHg
Some of this may be due to use of respiratory “mean”
PAWP in early studies rather than end-expiration
Key issues with PAWP measurement
How to measure the PAWP at rest?
› What is normal (<=15mmHg)?
› Where in the cardiac cycle?
› Where in the respiratory cycle?
What does the PAWP mean?
In diastole (MV open): P1=P2=P3
If we measure at end-diastole:
PAWP = LA pressure = LV
end-diastolic pressure
(LVEDP)
mean PAWP vs end-diastolic PAWP
Pre C wave (end-diastole)
mean PAWP roughly ~ end-diastolic PAWP = LVEDP
average of
peak and
trough of a-
wave
November 9, 2021
20
Impact of mean PAWP (averaged over cardiac cycle)
vs end-diastolic PAWP
Large V waves were associated with
negative DPG (PAD-PAWP)
End-diastolic PAWP vs mean PAWP
Mean PAWP represents pressure “felt” by the pulmonary circulation from the LA
mean PAWP ~ End-diastolic PAWP
Maron BA…Tedford RJ. JACC 2020 Dec 1.
mean PAWP > End-diastolic PAWP
Hemnes A et al. Chest. 2018 Aug 24.S0012-3692(18)32250-5.
Recommendations for adequate PAWP/LVEDP measurement
In respect to the cardiac cycle: measuring at end-diastole closely
reflects LVEDP
› In sinus rhythm, average the a-wave.
› In atrial fibrillation, measure the pressure 130-160msec after the
onset of QRS and before the V wave
› To determine the PVR (pre-capillary component), would use mean
PAWP
The presence of large V waves should be reported as this strongly
suggest LHD regardless of the PAWP.
Vachiery, Tedford, De Marco WSPH . ERJ 2019 Jan 24;53(1).
Maron BA…Tedford RJ. JACC 2020 Dec 1.
Key issues with PAWP measurement
How to measure the PAWP at rest
› What is normal?
› Where in the cardiac cycle?
› Where in the respiratory cycle?
Sometimes significant respiratory variation
PAWP
PAP
Could end-expiration overestimate?
LeVarge…Channick R. Eur Respir J. 2014 August;44(2):425–434
• Respirophasic variation correlated with BMI (? COPD/air trapping)
• 29% had pre-capillary phenotype but end-exp PAWP >15
329pts
44% of the cohort had post-capillary phenotype (all with respiratory mean PAWP ≤ 15mmHg)
that would also have been misclassified!
Equal impact on PAWP and LVEDP
LeVarge et al. Eur Respir J. 2014 August;44(2):425–434
“Routine measurement of LVEDP, in addition to adding procedural risk, is subject to the
same debates regarding respiratory variability as PAWP.”
N=30
Effect of obesity
Average BMI 46.2 (10.2)
Jawad et al. Ann Am Thorac Soc 2017
Dec; 14(12): 1861-1863
Effect of loading conditions
Maurides SP, Blankinship D…Houston BA.
J Card Fail 2020 Oct 7
Effect of loading conditions
Maurides SP, Blankinship D…Houston BA.
J Card Fail 2020 Oct 7
Recommendations for adequate PAWP/LVEDP measurement
In respect to the respiratory cycle:
› PH-LHD: we continue to recommend the assessment of PAWP at
end-expiration; Measuring as mean of the respiratory cycle would
reclassify many post-capillary PH patients to pre-capillary disease. (PH-
LHD)
› Lung Disease: As a result of exaggerated changes in intrathoracic
pressures during the breathing cycle in patients with lung disease, a
floating average over several breaths (without a breath hold) is
suggested for measurement of mean pressures, including the pulmonary
artery wedge pressure.
› I report both when significant respiratory variation
Partial Occlusion
Leatherman JW, Shapiro RS. Crit Care Med.
2003;31(1):93-97
To pulmonary
capillaries and
pulmonary veins
Distal PA
Distal PA
To pulmonary
capillaries and
pulmonary veins
To main PA
To main PA
How to measure a PAWP sat
What is the data – PAWP Sat?
Viray M, Tedford RJ. Circ HF 2020 Nov;13(11):e007981.
Back to our case: Does the PAWP fit?
Does the PAWP fit?
Does the PAWP fit?
No PAWP sat drawn
Case: Course
PAWP obtained (balloon partially inflated)
End-expiratory PAWP 12-13mmHg
Epoprostenol started and titrated to effect with good results
Final Take Home Points - PAWP
Check a PAWP saturation whenever PAWP is elevated to
confirm a complete occlusion
Always consider the clinical situation and know what you
expect to find before starting your case
Vachiery, Tedford, De Marco WSPH . ERJ 2019 Jan 24;53(1).
Maron BA…Tedford RJ. JACC 2020 Dec 1.
Cardiac Output Assessment
Modified Fick vs. TD Cardiac Output
1Hoeper MM et al. AJRCCM 1999;160:535–541.
2Hillis, L. D et al. Am. J. Cardiol. 1986 May 1;57(13):1201-2.
3Cigarroa, RG et al. Am. J. Med. 1989. 86:417–420
4Stevens Jl et al. JAMA. 1985;253:2240-2242.
Gold standard for measuring cardiac output is the direct Fick
method – requires measuring oxygen uptake (V02)1
Two commonly clinically used methods:
› Thermodilution cardiac output – concerns for inaccuracies at low2 (or
high) cardiac output and severe TR3; measured in triplicate at end-
expiration if possible4
› Fick [Q = (V02)/(AV02 difference x10)]
› Modified Fick assumes fixed basal oxygen consumption (125 mL
of 02/min/m2) – may not be accurate in ill patients with PAH and
HF; pulse oximetry to estimate arterial saturations can lead to
error
Estimated V02 vs Direct V02
Narang N et al. Circulation. 2014;129:203-210.)
535 Patients
Fick vs. TD Cardiac Output
Hoeper MM et al. AJRCCM 1999;160:535–541.
Yung GL et al. CHF. 2004;10(2 suppl 2):7–10
TD vs. direct Fick bias =
0.19L/min
TDCO vs Estimated Fick and Association
with Mortality
44
Opotowsky A…Tedford RJ. JAMA Cardiology 2018
45
Recommendations from 5th WSPH
(Nice)
 “The gold standard for CO measurement is the direct
Fick method, which requires direct measurement of the
oxygen uptake, a technique that is not widely available.
Therefore, it has become common practice in many
centers to use the indirect Fick method, which uses
estimated values for oxygen uptake derived from tables.
This approach is acceptable but lacks reliability.
Therefore, the preferred method of measuring CO is
thermodilution, which has been shown to provide
reliable measurements even in patients with very
low CO and/or severe tricuspid regurgitation.”
Hoeper MM et al. Definitions and Diagnosis of PH.
J Am Coll Cardiol 2013;62:D42–50
Timing of RHC for Diagnosis and Provocation
46
Why is timing important?
PAWP is not a constant number but a biological variable that is
affected by various factors, including fluid balance, intrathoracic
pressure, and others. 1
In many patients with left heart disease, it will be possible to at
least temporarily lower PAWP below 15 mm Hg with meticulous
afterload reduction and diuretic medication.2-3
Diuresis prior to RHC is common practice
1J Am Coll Cardiol. 2013;62(25_S)
2Lancet. 2011 Feb 19;377(9766):658-66
3Tampakakis E et al. JACC Heart Fail. 2015 Jan;3(1):9-16
Of 1174 patients with newly diagnosed cardiomyopathy
referred for endomyocardial biopsy, 616 had PAWP ≤
15 mmHg (52%).
Move toward earlier RHC?
Maron BA…Tedford RJ. JACC 2020 Dec 1.
50
Vachiery, Tedford, De Marco WSPH . ERJ 2019 Jan 24;53(1).
What if done later? Provocative Testing
Fujimoto N et al. Circulation. 2013;127:55-62
Subjects with HFpEF exhibited a
steeper increase in PAWP relative to
infused volume than healthy young
and older subjects (P≤0.005).
No ‘healthy’ subject would have increased PAWP > 18mmHg with 500cc saline
Borlaug BA. Circ Heart Fail. 2014;7:2-4
Ages
Young: 36±8
Old: 64±6
HFpEF 73±7
Fluid loading
18 pages long!
Exercise Hemodynamics ?
1. Type and duration of exercise?
2. Patient positioning – supine, upright, or in-between?
3. Where to assess in the respiratory cycle?
4. Impact of catheter ringing on systolic and diastolic
pressures?
5. What is normal?
6. How to assess cardiac output?
Multiple Considerations
WSPH Provocative Testing Recommendations
• In patients with a PAWP between 13 and 15 mmHg and high/intermediate probability of
PH LHD, provocative testing should be considered to uncover PH due to LHD. For
technical reasons and reliability of pressure recording, a fluid challenge is preferred over
exercise in the approach of differential diagnosis.
• A PAWP of > 18 mmHg immediately after administration of 500 ml of saline over 5
minutes is considered abnormal.
• However, how this should impact management is unknown. If PAH specific therapies are
initiated in patients with “abnormal” response, caution should be exercised, including
close monitoring of response and side effects.
Vachiery, Tedford, De Marco WSPH . ERJ 2019 Jan 24;53(1).
Summary
1.A thorough and meticulously performed right heart
catheterization is critical to make the diagnosis of PH
(preferably by a hemodynamic nerd like me)
2.You must get the PAWP right!
3.Consider early RHC when establishing diagnosis and
provocative testing if concern for LHD
Thank you - @RyanTedfordMD
MUSC HF Cardiologists .
Ryan Tedford
Brian Houston
Dharini Ramu
Michael Craig
Benny Van Bakel
Tom Di Salvo
Dan Judge
Greg Jackson
Chak Inampudi
Daniel Silverman
Bear Coney
Michael Zile
Sheldon Litwin
Heart Failure Surgeons .
Lucas Witer
Nick Pope
Sanford Zeigler
Marc Katz
Arman Kilic
Other slides
Balloon Occlusion – Half Inflation
Chest. 2011 Jan; 139(1): 115–121.
Interpretation of Tracings
Right atrial waveform – where to measure
www.anaesthesiauk.com
www.phaonlineuniv.org
End-diastolic pressure:
• Pre-C wave point (ideal)
• Average the highest and lowest “a” wave pressure
• If no a-wave (afib), identify the “Z” point (line from end of QRS to atrial tracing)
Normal values (0-5 mmHg)
Pulmonary artery waveform
Dicrotic notch
Step up in diastolic pressure
when moving from RV to PA
Normal mPAP ≤ 20 mmHg
PAWP waveform
• Step down in pressure from PAP
•Same principles as RAP measurement, but waveforms are delayed 0.08-0.12 s

More Related Content

What's hot

COLLATERAL ARTERIES
COLLATERAL ARTERIESCOLLATERAL ARTERIES
COLLATERAL ARTERIESMadhavbaug
 
Diastolic Dysfunction 2016
Diastolic Dysfunction 2016Diastolic Dysfunction 2016
Diastolic Dysfunction 2016drabhishekbabbu
 
Echocardiographic Evaluation of Hypertrophic Cardiomyopathy
Echocardiographic Evaluation of Hypertrophic CardiomyopathyEchocardiographic Evaluation of Hypertrophic Cardiomyopathy
Echocardiographic Evaluation of Hypertrophic CardiomyopathyHatem Soliman Aboumarie
 
Tte and tee assessment for asd closure 2
Tte and tee assessment for asd closure 2Tte and tee assessment for asd closure 2
Tte and tee assessment for asd closure 2Rahul Chalwade
 
No reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pciNo reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pcirahul arora
 
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATIONPraveen Nagula
 
Av canal defect
Av canal defectAv canal defect
Av canal defectdrsrb
 
M mode echocardiography
M mode echocardiographyM mode echocardiography
M mode echocardiographyFuad Farooq
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary interventionRamachandra Barik
 
Echo Differentiation of Restrictive Cardiomyopathy and Constrictive Pericarditis
Echo Differentiation of Restrictive Cardiomyopathy and Constrictive PericarditisEcho Differentiation of Restrictive Cardiomyopathy and Constrictive Pericarditis
Echo Differentiation of Restrictive Cardiomyopathy and Constrictive PericarditisJunhao Koh
 
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization ...
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization ...SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization ...
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization ...vaibhavyawalkar
 
Evaluation of severity of as
Evaluation of severity of asEvaluation of severity of as
Evaluation of severity of asDr. Rajesh Das
 
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATIONPraveen Nagula
 

What's hot (20)

COLLATERAL ARTERIES
COLLATERAL ARTERIESCOLLATERAL ARTERIES
COLLATERAL ARTERIES
 
heart failure device therapy
heart failure device therapyheart failure device therapy
heart failure device therapy
 
Diastolic Dysfunction 2016
Diastolic Dysfunction 2016Diastolic Dysfunction 2016
Diastolic Dysfunction 2016
 
Percutaneous left atrial appendage
Percutaneous left atrial appendagePercutaneous left atrial appendage
Percutaneous left atrial appendage
 
Echocardiographic Evaluation of Hypertrophic Cardiomyopathy
Echocardiographic Evaluation of Hypertrophic CardiomyopathyEchocardiographic Evaluation of Hypertrophic Cardiomyopathy
Echocardiographic Evaluation of Hypertrophic Cardiomyopathy
 
Tte and tee assessment for asd closure 2
Tte and tee assessment for asd closure 2Tte and tee assessment for asd closure 2
Tte and tee assessment for asd closure 2
 
Strain and strain rate
Strain  and strain rateStrain  and strain rate
Strain and strain rate
 
No reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pciNo reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pci
 
Ffr
FfrFfr
Ffr
 
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
 
Av canal defect
Av canal defectAv canal defect
Av canal defect
 
M mode echocardiography
M mode echocardiographyM mode echocardiography
M mode echocardiography
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary intervention
 
Echo Differentiation of Restrictive Cardiomyopathy and Constrictive Pericarditis
Echo Differentiation of Restrictive Cardiomyopathy and Constrictive PericarditisEcho Differentiation of Restrictive Cardiomyopathy and Constrictive Pericarditis
Echo Differentiation of Restrictive Cardiomyopathy and Constrictive Pericarditis
 
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization ...
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization ...SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization ...
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization ...
 
Mechanical Circulatory Support.pptx
Mechanical Circulatory Support.pptxMechanical Circulatory Support.pptx
Mechanical Circulatory Support.pptx
 
EISENMENGER SYNDROME- PAUL WOOD
EISENMENGER SYNDROME- PAUL WOODEISENMENGER SYNDROME- PAUL WOOD
EISENMENGER SYNDROME- PAUL WOOD
 
Evaluation of severity of as
Evaluation of severity of asEvaluation of severity of as
Evaluation of severity of as
 
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF AORTIC REGURGITATION
 
Pisa ppt
Pisa pptPisa ppt
Pisa ppt
 

Similar to Hemodynamic Evaluation of Pulmonary Hypertension: Principles and Best Practices

Joint Symposium of the HFSA and ACC
Joint Symposium of the HFSA and ACCJoint Symposium of the HFSA and ACC
Joint Symposium of the HFSA and ACCdrucsamal
 
Pulmonary hypertension and the Intensivist
Pulmonary hypertension and the IntensivistPulmonary hypertension and the Intensivist
Pulmonary hypertension and the IntensivistAndrew Ferguson
 
Pulmonary Hypertension for general physicians
Pulmonary Hypertension for general physicians Pulmonary Hypertension for general physicians
Pulmonary Hypertension for general physicians Sarfraz Saleemi
 
Catheterisation study and operability assessment
Catheterisation study and operability assessmentCatheterisation study and operability assessment
Catheterisation study and operability assessmentIndia CTVS
 
A New Horizon in Pulmonary Hypertension Management
A New Horizon in Pulmonary Hypertension Management A New Horizon in Pulmonary Hypertension Management
A New Horizon in Pulmonary Hypertension Management Dr.Mahmoud Abbas
 
Acute Decompensated Heart Failure
Acute Decompensated Heart FailureAcute Decompensated Heart Failure
Acute Decompensated Heart Failuredrucsamal
 
Acute Decompensated Heart Failure CSI13
Acute Decompensated Heart Failure CSI13Acute Decompensated Heart Failure CSI13
Acute Decompensated Heart Failure CSI13drucsamal
 
Novel strategies to improve diastolic function
Novel strategies to improve diastolic functionNovel strategies to improve diastolic function
Novel strategies to improve diastolic functiondrucsamal
 
Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021Duke Heart
 
Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?drucsamal
 
Pulmonary Arterial Hypetension.pptx
Pulmonary Arterial Hypetension.pptxPulmonary Arterial Hypetension.pptx
Pulmonary Arterial Hypetension.pptxNannikaPradhan
 
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...YolaNewary1
 
Pulmonary hypertension and anesthesia
Pulmonary hypertension and anesthesiaPulmonary hypertension and anesthesia
Pulmonary hypertension and anesthesiaWesam Mousa
 
Treatment strategies for pulmonary hypertension
Treatment strategies for pulmonary hypertensionTreatment strategies for pulmonary hypertension
Treatment strategies for pulmonary hypertensionSarfraz Saleemi
 
Predicting fluid response in the ICU
Predicting fluid response in the ICUPredicting fluid response in the ICU
Predicting fluid response in the ICUAndrew Ferguson
 
Patent ductus arteriosus 2014
Patent ductus arteriosus 2014Patent ductus arteriosus 2014
Patent ductus arteriosus 2014Nav Kov
 
Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019hospital
 

Similar to Hemodynamic Evaluation of Pulmonary Hypertension: Principles and Best Practices (20)

Joint Symposium of the HFSA and ACC
Joint Symposium of the HFSA and ACCJoint Symposium of the HFSA and ACC
Joint Symposium of the HFSA and ACC
 
Pulmonary hypertension and the Intensivist
Pulmonary hypertension and the IntensivistPulmonary hypertension and the Intensivist
Pulmonary hypertension and the Intensivist
 
Pulmonary Hypertension for general physicians
Pulmonary Hypertension for general physicians Pulmonary Hypertension for general physicians
Pulmonary Hypertension for general physicians
 
Catheterisation study and operability assessment
Catheterisation study and operability assessmentCatheterisation study and operability assessment
Catheterisation study and operability assessment
 
A New Horizon in Pulmonary Hypertension Management
A New Horizon in Pulmonary Hypertension Management A New Horizon in Pulmonary Hypertension Management
A New Horizon in Pulmonary Hypertension Management
 
Acute Decompensated Heart Failure
Acute Decompensated Heart FailureAcute Decompensated Heart Failure
Acute Decompensated Heart Failure
 
Acute Decompensated Heart Failure CSI13
Acute Decompensated Heart Failure CSI13Acute Decompensated Heart Failure CSI13
Acute Decompensated Heart Failure CSI13
 
Novel strategies to improve diastolic function
Novel strategies to improve diastolic functionNovel strategies to improve diastolic function
Novel strategies to improve diastolic function
 
Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021
 
Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?
 
Pah management
Pah managementPah management
Pah management
 
Pulmonary Hypertension.pptx
Pulmonary Hypertension.pptxPulmonary Hypertension.pptx
Pulmonary Hypertension.pptx
 
Pulmonary Arterial Hypetension.pptx
Pulmonary Arterial Hypetension.pptxPulmonary Arterial Hypetension.pptx
Pulmonary Arterial Hypetension.pptx
 
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...
Evaluation and Management of pulmonary artery hypertension - dr sandeep mohan...
 
Pulmonary hypertension and anesthesia
Pulmonary hypertension and anesthesiaPulmonary hypertension and anesthesia
Pulmonary hypertension and anesthesia
 
Pulmonary Hypertension at the Crossroads of Current Clinical Challenges and N...
Pulmonary Hypertension at the Crossroads of Current Clinical Challenges and N...Pulmonary Hypertension at the Crossroads of Current Clinical Challenges and N...
Pulmonary Hypertension at the Crossroads of Current Clinical Challenges and N...
 
Treatment strategies for pulmonary hypertension
Treatment strategies for pulmonary hypertensionTreatment strategies for pulmonary hypertension
Treatment strategies for pulmonary hypertension
 
Predicting fluid response in the ICU
Predicting fluid response in the ICUPredicting fluid response in the ICU
Predicting fluid response in the ICU
 
Patent ductus arteriosus 2014
Patent ductus arteriosus 2014Patent ductus arteriosus 2014
Patent ductus arteriosus 2014
 
Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019
 

More from Duke Heart

CTEPH Surgical and BPA Treatment Update
CTEPH Surgical and BPA Treatment UpdateCTEPH Surgical and BPA Treatment Update
CTEPH Surgical and BPA Treatment UpdateDuke Heart
 
CTEPH Diagnosis and Medical Treatment Update
CTEPH Diagnosis and Medical Treatment UpdateCTEPH Diagnosis and Medical Treatment Update
CTEPH Diagnosis and Medical Treatment UpdateDuke Heart
 
Group V Pulmonary Hypertension
Group V Pulmonary HypertensionGroup V Pulmonary Hypertension
Group V Pulmonary HypertensionDuke Heart
 
Updates in Group 5 PH: ESRD, SCD, MPD
Updates in Group 5 PH: ESRD, SCD, MPDUpdates in Group 5 PH: ESRD, SCD, MPD
Updates in Group 5 PH: ESRD, SCD, MPDDuke Heart
 
Imaging Assessment in Pulmonary Hypertension
Imaging Assessment in Pulmonary HypertensionImaging Assessment in Pulmonary Hypertension
Imaging Assessment in Pulmonary HypertensionDuke Heart
 
Mechanical Circulatory Support of the Failing Right Ventricle
Mechanical Circulatory Support of the Failing Right VentricleMechanical Circulatory Support of the Failing Right Ventricle
Mechanical Circulatory Support of the Failing Right VentricleDuke Heart
 
Managing PH Therapy Access
Managing PH Therapy AccessManaging PH Therapy Access
Managing PH Therapy AccessDuke Heart
 
The Cost of PH - How Do We Manage This?
The Cost of PH - How Do We Manage This? The Cost of PH - How Do We Manage This?
The Cost of PH - How Do We Manage This? Duke Heart
 
Pulmonary Hypertension Overview 2023
Pulmonary Hypertension Overview 2023Pulmonary Hypertension Overview 2023
Pulmonary Hypertension Overview 2023Duke Heart
 
Pulmonary Hypertension in an Adult with Complex Congenital Heart Disease
Pulmonary Hypertension in an Adult with Complex Congenital Heart DiseasePulmonary Hypertension in an Adult with Complex Congenital Heart Disease
Pulmonary Hypertension in an Adult with Complex Congenital Heart DiseaseDuke Heart
 
Perplexing PH Case 2
Perplexing PH Case 2Perplexing PH Case 2
Perplexing PH Case 2Duke Heart
 
Perplexing PH Case 1
Perplexing PH Case 1Perplexing PH Case 1
Perplexing PH Case 1Duke Heart
 
PH in the Real World_Case Studies.pptx
PH in the Real World_Case Studies.pptxPH in the Real World_Case Studies.pptx
PH in the Real World_Case Studies.pptxDuke Heart
 
PH in the Real World - Case Studies
PH in the Real World - Case StudiesPH in the Real World - Case Studies
PH in the Real World - Case StudiesDuke Heart
 
Lung Transplantation for PAH
Lung Transplantation for PAHLung Transplantation for PAH
Lung Transplantation for PAHDuke Heart
 
PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022Duke Heart
 
Transitions in PAH Therapy.pptx
Transitions in PAH Therapy.pptxTransitions in PAH Therapy.pptx
Transitions in PAH Therapy.pptxDuke Heart
 
The Case for Systematic Risk Assessment in PAH.pptx
The Case for Systematic Risk Assessment in PAH.pptxThe Case for Systematic Risk Assessment in PAH.pptx
The Case for Systematic Risk Assessment in PAH.pptxDuke Heart
 
Risk Assessment: Yes...BUT
Risk Assessment: Yes...BUTRisk Assessment: Yes...BUT
Risk Assessment: Yes...BUTDuke Heart
 
What's New in Congenital Heart Disease PAH?
What's New in Congenital Heart Disease PAH?What's New in Congenital Heart Disease PAH?
What's New in Congenital Heart Disease PAH?Duke Heart
 

More from Duke Heart (20)

CTEPH Surgical and BPA Treatment Update
CTEPH Surgical and BPA Treatment UpdateCTEPH Surgical and BPA Treatment Update
CTEPH Surgical and BPA Treatment Update
 
CTEPH Diagnosis and Medical Treatment Update
CTEPH Diagnosis and Medical Treatment UpdateCTEPH Diagnosis and Medical Treatment Update
CTEPH Diagnosis and Medical Treatment Update
 
Group V Pulmonary Hypertension
Group V Pulmonary HypertensionGroup V Pulmonary Hypertension
Group V Pulmonary Hypertension
 
Updates in Group 5 PH: ESRD, SCD, MPD
Updates in Group 5 PH: ESRD, SCD, MPDUpdates in Group 5 PH: ESRD, SCD, MPD
Updates in Group 5 PH: ESRD, SCD, MPD
 
Imaging Assessment in Pulmonary Hypertension
Imaging Assessment in Pulmonary HypertensionImaging Assessment in Pulmonary Hypertension
Imaging Assessment in Pulmonary Hypertension
 
Mechanical Circulatory Support of the Failing Right Ventricle
Mechanical Circulatory Support of the Failing Right VentricleMechanical Circulatory Support of the Failing Right Ventricle
Mechanical Circulatory Support of the Failing Right Ventricle
 
Managing PH Therapy Access
Managing PH Therapy AccessManaging PH Therapy Access
Managing PH Therapy Access
 
The Cost of PH - How Do We Manage This?
The Cost of PH - How Do We Manage This? The Cost of PH - How Do We Manage This?
The Cost of PH - How Do We Manage This?
 
Pulmonary Hypertension Overview 2023
Pulmonary Hypertension Overview 2023Pulmonary Hypertension Overview 2023
Pulmonary Hypertension Overview 2023
 
Pulmonary Hypertension in an Adult with Complex Congenital Heart Disease
Pulmonary Hypertension in an Adult with Complex Congenital Heart DiseasePulmonary Hypertension in an Adult with Complex Congenital Heart Disease
Pulmonary Hypertension in an Adult with Complex Congenital Heart Disease
 
Perplexing PH Case 2
Perplexing PH Case 2Perplexing PH Case 2
Perplexing PH Case 2
 
Perplexing PH Case 1
Perplexing PH Case 1Perplexing PH Case 1
Perplexing PH Case 1
 
PH in the Real World_Case Studies.pptx
PH in the Real World_Case Studies.pptxPH in the Real World_Case Studies.pptx
PH in the Real World_Case Studies.pptx
 
PH in the Real World - Case Studies
PH in the Real World - Case StudiesPH in the Real World - Case Studies
PH in the Real World - Case Studies
 
Lung Transplantation for PAH
Lung Transplantation for PAHLung Transplantation for PAH
Lung Transplantation for PAH
 
PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022PAH Drug Discovery and Development: State of the Art in 2022
PAH Drug Discovery and Development: State of the Art in 2022
 
Transitions in PAH Therapy.pptx
Transitions in PAH Therapy.pptxTransitions in PAH Therapy.pptx
Transitions in PAH Therapy.pptx
 
The Case for Systematic Risk Assessment in PAH.pptx
The Case for Systematic Risk Assessment in PAH.pptxThe Case for Systematic Risk Assessment in PAH.pptx
The Case for Systematic Risk Assessment in PAH.pptx
 
Risk Assessment: Yes...BUT
Risk Assessment: Yes...BUTRisk Assessment: Yes...BUT
Risk Assessment: Yes...BUT
 
What's New in Congenital Heart Disease PAH?
What's New in Congenital Heart Disease PAH?What's New in Congenital Heart Disease PAH?
What's New in Congenital Heart Disease PAH?
 

Recently uploaded

High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipurparulsinha
 
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Miss joya
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls ServiceMiss joya
 
Call Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
Call Girl Chennai Indira 9907093804 Independent Call Girls Service ChennaiCall Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
Call Girl Chennai Indira 9907093804 Independent Call Girls Service ChennaiNehru place Escorts
 
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort ServiceCall Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Serviceparulsinha
 
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...narwatsonia7
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...CALL GIRLS
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Servicemakika9823
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...Miss joya
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.MiadAlsulami
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...narwatsonia7
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Miss joya
 
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Nehru place Escorts
 
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...narwatsonia7
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...narwatsonia7
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...narwatsonia7
 

Recently uploaded (20)

High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
 
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
 
Call Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
Call Girl Chennai Indira 9907093804 Independent Call Girls Service ChennaiCall Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
Call Girl Chennai Indira 9907093804 Independent Call Girls Service Chennai
 
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort ServiceCall Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
 
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
 
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
 
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
 

Hemodynamic Evaluation of Pulmonary Hypertension: Principles and Best Practices

  • 1. Ryan J. Tedford, MD, FACC, FAHA, FHFSA Peter C. Gazes Endowed Chair and Professor of Medicine Section Chief, Heart Failure Medical Director, Cardiac Transplant Medical University of South Carolina, Charleston, SC Hemodynamic Evaluation of Pulmonary Hypertension— Principles and Best Practices 13TH ANNUAL NORTH CAROLINA RESEARCH TRIANGLE PULMONARY HYPERTENSION SYMPOSIUM November 5, 2021 @RyanTedfordMD
  • 2. Disclosures Medtronic/Accerelon –Steering Committees Actelion/Merck – Hemodynamic Core Lab Abiomed – Research Advisory Group Consultant –United Therapeutics, Medtronic, Aria CV, Gradient, Itamar, Edward LifeSciences, Eidos Therapeutics, Lexicon, CareDx I Love Right Heart Catheterizations and Hemodynamics! Ryan J. Tedford, MD
  • 3. Objectives 1. Review best practices of the right heart catheterization 2. Detail waveform interpretation including considerations of how to accurately measure the PAWP 3. Appraise importance of RHC timing and provocative challenges in the diagnosis of PH
  • 4. Two Basic and Critical Principles 1. Always perform a right heart catheterization BEFORE starting any PAH specific therapy 2. PAH specific therapy is not recommended in LHD 2015 ERS/ESC PH guidelines
  • 5. Case 35 year old woman with IPAH, previously vasoreactive (treated with calcium channel blocker therapy) › Lost vasoreactivity – treated with riocuiguat and ambrisentan › Progressive symptoms – near syncope and volume overload › Referred for RHC prior to planned initiation of IV epoprostenol
  • 6. RHC SBP 96/70, HR 98 RA 9, RV 130/20, PA 130/60 (90), W 40 CO/CI - 4.5/2.6 (TD) Nitroprusside – PA 115/61 (81), no PAWP or CO/CI recorded Sent back to MICU Phone call: What to do with the PAWP of 40mmHg? Should we start epoprostenol or not?
  • 7. Before you begin Know what to expect Get comfortable (you and the patient)! Patient positioning › Patient is supine with legs flat › Right internal jugular access (or antecubital) unless contraindication › No sedation is preferable; if absolutely necessary, premedication with oral medication much preferred over IV administration
  • 8. Before you begin › Level the transducer in a supine patient : › Left atrium: Mid chest is halfway between the anterior sternum and the bed surface. › Measure it! › Zero the transducer Kovacs g. Eur Respir J. 2013 Dec;42(6):1586-94. *J Am Coll Cardiol. 2013;62(25_S)
  • 9. General Principles – RHC measurements All pressure tracings must be accompanied by a simultaneous ECG tracing (directly above or below the pressure tracing) which is used for timing and analysis of waveforms. If PVC’s are present, the tracings should be re-recorded unless PVC burden is too high to allow for a PVC-free recording. All hemodynamic recordings should be taken while patient is breathing quietly and spontaneously. No breath hold maneuvers should be used.1 Do not record any data while the patient is restless, talking, or coughing. 1Hoeper MM et al. Definitions and Diagnosis of PH. J Am Coll Cardiol 2013;62:D42–50
  • 10. Examining The Tracing Quality If pressure tracings appear dampened (for example, no dichotic notch is seen on the PA pressure tracing), re-flush the catheter and tubing to insure there are no air bubbles in either. Watson CA et al. Anaesthesia and Intensive Care Medicine (13), 2012, 116-120. Maron BA…Tedford RJ. JACC 2020 Dec 1.
  • 11. Examining The Tracing Quality If catheter ringing is present, try flushing all tubing first, and if not successful, introducing a small amount of blood back into the catheter may be helpful (to change the resonant frequency) – must be careful to overdamp the signal. Watson CA et al. Anaesthesia and Intensive Care Medicine (13), 2012, 116-120. Maron BA…Tedford RJ. JACC 2020 Dec 1.
  • 12. Dealing with Catheter Ringing Lim MJ. Hemodynamic Rounds, 3rd edition, 2009 Maron BA…Tedford RJ. JACC 2020 Dec 1.
  • 13. PAWP is the sole discriminator of PH – critical to get it right Maron BA…Tedford RJ. JACC 2020 Dec 1.
  • 14. Key issues with PAWP measurement How to measure the PAWP at rest? › What is normal (<=15mmHg)? › Where in the cardiac cycle? › Where in the respiratory cycle?
  • 15. What is the normal value of PAWP ? 1958 – The left atrial pressure averaged 2-3 mmHg 1 1975 – The « capillary » pressure is in the order of 6-9 mmHg and may even reach 12 mmHg; …seems little affected by age. It gives a good indication of the mean LAP provided that it does not exceed 25 mmHg 2 2002 – The inclusion criteria were… a pulmonary capillary wedge pressure < 15 mmHg, and PVR > 240 dyn·sec·cm-5 2007 – mean PAWP > 12 mmHg or LVEDP > 16 mmHg 4 2016 – PAWP ≥ 15 mmHg or LVEDP ≥16 mmHg 5 1. Wood P. Br Heart J. 1958;20:557-70. 2. Proceedings of the WHO Symposium 1975. 3. Rubin LJ et al. N Engl J Med. 2002; 346:896- 903. 4. Paulus W et al. European Heart Journal (2007) 28, 2539– 2550. 5. Ponikowski P et al. Eur Heart J 2016; 37, 2129–2200
  • 16. What is the normal PAWP? The “normal PAWP” has creeped up over time Many early studies considered a “normal PAWP” < 12 mmHg Some of this may be due to use of respiratory “mean” PAWP in early studies rather than end-expiration
  • 17. Key issues with PAWP measurement How to measure the PAWP at rest? › What is normal (<=15mmHg)? › Where in the cardiac cycle? › Where in the respiratory cycle?
  • 18. What does the PAWP mean? In diastole (MV open): P1=P2=P3 If we measure at end-diastole: PAWP = LA pressure = LV end-diastolic pressure (LVEDP)
  • 19. mean PAWP vs end-diastolic PAWP Pre C wave (end-diastole) mean PAWP roughly ~ end-diastolic PAWP = LVEDP average of peak and trough of a- wave
  • 20. November 9, 2021 20 Impact of mean PAWP (averaged over cardiac cycle) vs end-diastolic PAWP Large V waves were associated with negative DPG (PAD-PAWP)
  • 21. End-diastolic PAWP vs mean PAWP Mean PAWP represents pressure “felt” by the pulmonary circulation from the LA mean PAWP ~ End-diastolic PAWP Maron BA…Tedford RJ. JACC 2020 Dec 1. mean PAWP > End-diastolic PAWP
  • 22. Hemnes A et al. Chest. 2018 Aug 24.S0012-3692(18)32250-5.
  • 23. Recommendations for adequate PAWP/LVEDP measurement In respect to the cardiac cycle: measuring at end-diastole closely reflects LVEDP › In sinus rhythm, average the a-wave. › In atrial fibrillation, measure the pressure 130-160msec after the onset of QRS and before the V wave › To determine the PVR (pre-capillary component), would use mean PAWP The presence of large V waves should be reported as this strongly suggest LHD regardless of the PAWP. Vachiery, Tedford, De Marco WSPH . ERJ 2019 Jan 24;53(1). Maron BA…Tedford RJ. JACC 2020 Dec 1.
  • 24. Key issues with PAWP measurement How to measure the PAWP at rest › What is normal? › Where in the cardiac cycle? › Where in the respiratory cycle?
  • 25. Sometimes significant respiratory variation PAWP PAP
  • 26. Could end-expiration overestimate? LeVarge…Channick R. Eur Respir J. 2014 August;44(2):425–434 • Respirophasic variation correlated with BMI (? COPD/air trapping) • 29% had pre-capillary phenotype but end-exp PAWP >15 329pts 44% of the cohort had post-capillary phenotype (all with respiratory mean PAWP ≤ 15mmHg) that would also have been misclassified!
  • 27. Equal impact on PAWP and LVEDP LeVarge et al. Eur Respir J. 2014 August;44(2):425–434 “Routine measurement of LVEDP, in addition to adding procedural risk, is subject to the same debates regarding respiratory variability as PAWP.” N=30
  • 28. Effect of obesity Average BMI 46.2 (10.2) Jawad et al. Ann Am Thorac Soc 2017 Dec; 14(12): 1861-1863
  • 29. Effect of loading conditions Maurides SP, Blankinship D…Houston BA. J Card Fail 2020 Oct 7
  • 30. Effect of loading conditions Maurides SP, Blankinship D…Houston BA. J Card Fail 2020 Oct 7
  • 31. Recommendations for adequate PAWP/LVEDP measurement In respect to the respiratory cycle: › PH-LHD: we continue to recommend the assessment of PAWP at end-expiration; Measuring as mean of the respiratory cycle would reclassify many post-capillary PH patients to pre-capillary disease. (PH- LHD) › Lung Disease: As a result of exaggerated changes in intrathoracic pressures during the breathing cycle in patients with lung disease, a floating average over several breaths (without a breath hold) is suggested for measurement of mean pressures, including the pulmonary artery wedge pressure. › I report both when significant respiratory variation
  • 32. Partial Occlusion Leatherman JW, Shapiro RS. Crit Care Med. 2003;31(1):93-97
  • 33. To pulmonary capillaries and pulmonary veins Distal PA Distal PA To pulmonary capillaries and pulmonary veins To main PA To main PA How to measure a PAWP sat
  • 34. What is the data – PAWP Sat? Viray M, Tedford RJ. Circ HF 2020 Nov;13(11):e007981.
  • 35. Back to our case: Does the PAWP fit?
  • 37. Does the PAWP fit? No PAWP sat drawn
  • 38. Case: Course PAWP obtained (balloon partially inflated) End-expiratory PAWP 12-13mmHg Epoprostenol started and titrated to effect with good results
  • 39. Final Take Home Points - PAWP Check a PAWP saturation whenever PAWP is elevated to confirm a complete occlusion Always consider the clinical situation and know what you expect to find before starting your case Vachiery, Tedford, De Marco WSPH . ERJ 2019 Jan 24;53(1). Maron BA…Tedford RJ. JACC 2020 Dec 1.
  • 41. Modified Fick vs. TD Cardiac Output 1Hoeper MM et al. AJRCCM 1999;160:535–541. 2Hillis, L. D et al. Am. J. Cardiol. 1986 May 1;57(13):1201-2. 3Cigarroa, RG et al. Am. J. Med. 1989. 86:417–420 4Stevens Jl et al. JAMA. 1985;253:2240-2242. Gold standard for measuring cardiac output is the direct Fick method – requires measuring oxygen uptake (V02)1 Two commonly clinically used methods: › Thermodilution cardiac output – concerns for inaccuracies at low2 (or high) cardiac output and severe TR3; measured in triplicate at end- expiration if possible4 › Fick [Q = (V02)/(AV02 difference x10)] › Modified Fick assumes fixed basal oxygen consumption (125 mL of 02/min/m2) – may not be accurate in ill patients with PAH and HF; pulse oximetry to estimate arterial saturations can lead to error
  • 42. Estimated V02 vs Direct V02 Narang N et al. Circulation. 2014;129:203-210.) 535 Patients
  • 43. Fick vs. TD Cardiac Output Hoeper MM et al. AJRCCM 1999;160:535–541. Yung GL et al. CHF. 2004;10(2 suppl 2):7–10 TD vs. direct Fick bias = 0.19L/min
  • 44. TDCO vs Estimated Fick and Association with Mortality 44 Opotowsky A…Tedford RJ. JAMA Cardiology 2018
  • 45. 45 Recommendations from 5th WSPH (Nice)  “The gold standard for CO measurement is the direct Fick method, which requires direct measurement of the oxygen uptake, a technique that is not widely available. Therefore, it has become common practice in many centers to use the indirect Fick method, which uses estimated values for oxygen uptake derived from tables. This approach is acceptable but lacks reliability. Therefore, the preferred method of measuring CO is thermodilution, which has been shown to provide reliable measurements even in patients with very low CO and/or severe tricuspid regurgitation.” Hoeper MM et al. Definitions and Diagnosis of PH. J Am Coll Cardiol 2013;62:D42–50
  • 46. Timing of RHC for Diagnosis and Provocation 46
  • 47. Why is timing important? PAWP is not a constant number but a biological variable that is affected by various factors, including fluid balance, intrathoracic pressure, and others. 1 In many patients with left heart disease, it will be possible to at least temporarily lower PAWP below 15 mm Hg with meticulous afterload reduction and diuretic medication.2-3 Diuresis prior to RHC is common practice 1J Am Coll Cardiol. 2013;62(25_S) 2Lancet. 2011 Feb 19;377(9766):658-66 3Tampakakis E et al. JACC Heart Fail. 2015 Jan;3(1):9-16
  • 48. Of 1174 patients with newly diagnosed cardiomyopathy referred for endomyocardial biopsy, 616 had PAWP ≤ 15 mmHg (52%).
  • 49. Move toward earlier RHC? Maron BA…Tedford RJ. JACC 2020 Dec 1.
  • 50. 50 Vachiery, Tedford, De Marco WSPH . ERJ 2019 Jan 24;53(1). What if done later? Provocative Testing
  • 51. Fujimoto N et al. Circulation. 2013;127:55-62 Subjects with HFpEF exhibited a steeper increase in PAWP relative to infused volume than healthy young and older subjects (P≤0.005). No ‘healthy’ subject would have increased PAWP > 18mmHg with 500cc saline Borlaug BA. Circ Heart Fail. 2014;7:2-4 Ages Young: 36±8 Old: 64±6 HFpEF 73±7 Fluid loading
  • 52. 18 pages long! Exercise Hemodynamics ?
  • 53. 1. Type and duration of exercise? 2. Patient positioning – supine, upright, or in-between? 3. Where to assess in the respiratory cycle? 4. Impact of catheter ringing on systolic and diastolic pressures? 5. What is normal? 6. How to assess cardiac output? Multiple Considerations
  • 54. WSPH Provocative Testing Recommendations • In patients with a PAWP between 13 and 15 mmHg and high/intermediate probability of PH LHD, provocative testing should be considered to uncover PH due to LHD. For technical reasons and reliability of pressure recording, a fluid challenge is preferred over exercise in the approach of differential diagnosis. • A PAWP of > 18 mmHg immediately after administration of 500 ml of saline over 5 minutes is considered abnormal. • However, how this should impact management is unknown. If PAH specific therapies are initiated in patients with “abnormal” response, caution should be exercised, including close monitoring of response and side effects. Vachiery, Tedford, De Marco WSPH . ERJ 2019 Jan 24;53(1).
  • 55. Summary 1.A thorough and meticulously performed right heart catheterization is critical to make the diagnosis of PH (preferably by a hemodynamic nerd like me) 2.You must get the PAWP right! 3.Consider early RHC when establishing diagnosis and provocative testing if concern for LHD
  • 56. Thank you - @RyanTedfordMD MUSC HF Cardiologists . Ryan Tedford Brian Houston Dharini Ramu Michael Craig Benny Van Bakel Tom Di Salvo Dan Judge Greg Jackson Chak Inampudi Daniel Silverman Bear Coney Michael Zile Sheldon Litwin Heart Failure Surgeons . Lucas Witer Nick Pope Sanford Zeigler Marc Katz Arman Kilic
  • 58. Balloon Occlusion – Half Inflation Chest. 2011 Jan; 139(1): 115–121.
  • 60. Right atrial waveform – where to measure www.anaesthesiauk.com www.phaonlineuniv.org End-diastolic pressure: • Pre-C wave point (ideal) • Average the highest and lowest “a” wave pressure • If no a-wave (afib), identify the “Z” point (line from end of QRS to atrial tracing) Normal values (0-5 mmHg)
  • 61. Pulmonary artery waveform Dicrotic notch Step up in diastolic pressure when moving from RV to PA Normal mPAP ≤ 20 mmHg
  • 62. PAWP waveform • Step down in pressure from PAP •Same principles as RAP measurement, but waveforms are delayed 0.08-0.12 s

Editor's Notes

  1. To zero the transducer, the stopcock closest to the transducer is closed to the patient. Remove the sterile protective cap from the stopcock port, exposing the hemodynamic monitoring system to air. The monitor's zero function key is activated to offset pressure in the transducer, setting the pressure to zero. Open the stopcock to the patient and replace the sterile cap on the stopcock port. Zeroing ensures that when the transducer stopcock is open to the patient and closed to air, the only pressure on the transducer will be from the vessel/heart chamber being monitored.
  2. Damping describes the (usually exponential) decrease in amplitude of an oscillating system with time due to dissipation of energy by frictional forces.
  3. Resonance describes the situation where a periodic force is applied to a system which is capable of oscillation. The amplitude of the resulting oscillation is greatest when the force is applied at a frequency which is equal to one of natural frequencies of oscillation (fundamental or harmonic frequencies) of the system. Thus if the frequency of the transmitted waveform is close to the natural resonant frequencies of the transducer system, the amplitude of the resultant waveform will be increased, and an artefactual raised reading will result.
  4. Current guidelines recommend measurement of pulmonary artery wedge pressure (PAWP) at end-expiration. However, this recommendation is not universally followed and may not be physiologically appropriate. We investigated the performance of end-expiratory PAWP in the evaluation of precapillary pulmonary hypertension patients. 329 spontaneously breathing patients undergoing right heart catheterisation were retrospectively classified as having a precapillary, post-capillary or mixed phenotype based on standardised clinical criteria. Tracings were reviewed to compare end-expiratory PAWP with PAWP averaged throughout the respiratory cycle; these values were correlated with the clinical classifications. Predictors of large respirophasic variation in PAWP were determined. Elevated end-expiratory PAWP (>15 mmHg) occurred in 29% of subjects with precapillary phenotype. There were no differences in demographics or clinical history between those with elevated and normal end-expiratory PAWP. Those with elevated end-expiratory PAWP had greater right atrial pressure and respirophasic PAWP variation. Among all subjects, the magnitude of respirophasic variation in PAWP was positively correlated with body mass index and respirophasic variation in left ventricular end-diastolic pressure. A significant proportion of precapillary pulmonary hypertension patients have end-expiratory PAWP >15 mmHg. Spontaneous positive end-expiratory intrathoracic pressure may contribute; in those cases, PAWP averaged throughout respiration may be a more accurate measuremen
  5. Current guidelines recommend measurement of pulmonary artery wedge pressure (PAWP) at end-expiration. However, this recommendation is not universally followed and may not be physiologically appropriate. We investigated the performance of end-expiratory PAWP in the evaluation of precapillary pulmonary hypertension patients. 329 spontaneously breathing patients undergoing right heart catheterisation were retrospectively classified as having a precapillary, post-capillary or mixed phenotype based on standardised clinical criteria. Tracings were reviewed to compare end-expiratory PAWP with PAWP averaged throughout the respiratory cycle; these values were correlated with the clinical classifications. Predictors of large respirophasic variation in PAWP were determined. Elevated end-expiratory PAWP (>15 mmHg) occurred in 29% of subjects with precapillary phenotype. There were no differences in demographics or clinical history between those with elevated and normal end-expiratory PAWP. Those with elevated end-expiratory PAWP had greater right atrial pressure and respirophasic PAWP variation. Among all subjects, the magnitude of respirophasic variation in PAWP was positively correlated with body mass index and respirophasic variation in left ventricular end-diastolic pressure. A significant proportion of precapillary pulmonary hypertension patients have end-expiratory PAWP >15 mmHg. Spontaneous positive end-expiratory intrathoracic pressure may contribute; in those cases, PAWP averaged throughout respiration may be a more accurate measuremen
  6. CLINICAL INVESTIGATIONS Overestimation of pulmonary artery occlusion pressure in pulmonary hypertension due to partial occlusion Leatherman, James W. MD; Shapiro, Robert S. MD Author InformationCritical Care Medicine: January 2003 - Volume 31 - Issue 1 - p 93-97 Abstract Objective  To evaluate partial occlusion in patients with pulmonary hypertension with regard to a) the degree to which it leads to overestimation of pulmonary artery occlusion pressure (Ppao) and b) identification of factors that could enhance its recognition. Design  Observational descriptive study. Setting  Medical intensive care unit. Patients  Fourteen patients with pulmonary hypertension and an increased pulmonary artery diastolic pressure (Ppad) − Ppao gradient (≥10 mm Hg). Interventions  None. Measurements and Main Results  The Ppao was recorded during partial occlusion (partial Ppao) and after catheter repositioning to obtain a lower, more accurate value (best Ppao). The error due to partial occlusion, defined as the difference between the partial Ppao and the best Ppao, was 13 ± 5 mm Hg (range, 6–21 mm Hg). The previously widened Ppad − Ppao gradient invariably narrowed during partial occlusion and then increased by 13 ± 5 mm Hg (range, 5–23) during the best Ppao measurement. There was a moderate correlation between the error due to partial occlusion (partial Ppao − best Ppao) and both the mean pulmonary artery pressure (r = .77, p < .01) and the Ppad − Ppao gradient (r = .79, p < .01). Conclusions  Partial occlusion in patients with pulmonary hypertension may lead to significant overestimation of the Ppao and should be suspected when there is a substantial increase in the Ppao without a concomitant increase in the Ppad, as reflected by a marked narrowing of a previously widened Ppad − Ppao gradient.
  7. Dehmer: V̇O2 (ml/min) = 125 (ml/min/m2) × body surface area (BSA,m2), with BSA calculated according to the formula of Dubois BSA (m2) = 0.007184 × Weight (kg) 0.425 × Height (cm) 0.725. LaFarge: V̇O2 (ml/min) = 138.1 – (X × logeage) + (0.378 × Heart Rate) × BSA (Men: X = 11.49; Women: X = 17.04); Bergstra: V̇O2 (ml/min) = 157.3 × BSA + X – (10.5 × logeage)+ 4.8 (Men: X = 10; Women = 0). Background—The Fick principle (cardiac output = oxygen uptake (V̇O2)/systemic arterio-venous oxygen difference) is used to determine cardiac output in numerous clinical situations. However, estimated rather than measured V̇O2 is commonly used because of complexities of the measurement, though the accuracy of estimation remains uncertain in contemporary clinical practice. Methods and Results—From 1996 to 2005, resting V̇O2 was measured via the Douglas bag technique in adult patients undergoing right heart catheterization. Resting V̇O2 was estimated by each of 3 published formulae. Agreement between measured and estimated V̇O2 was assessed overall, and across strata of body mass index, sex, and age. The study included 535 patients, with mean age 55 yrs, mean body mass index 28.4 kg/m2; 53% women; 64% non-white. Mean (±standard deviation) measured V̇O2 was 241 ± 57 ml/min. Measured V̇O2 differed significantly from values derived from all 3 formulae, with median (interquartile range) absolute differences of 28.4 (13.1, 50.2) ml/min, 37.7 (19.4, 63.3) ml/min, and 31.7 (14.4, 54.5) ml/min, for the formulae of Dehmer, LaFarge, and Bergstra, respectively (P<0.0001 for each). The measured and estimated values differed by >25% in 17% to 25% of patients depending on the formula used. Median absolute differences were greater in severely obese patients (body mass index > 40 kg/m2), but were not affected by sex or age. Conclusions—Estimates of resting V̇O2 derived from conventional formulae are inaccurate, especially in severely obese individuals. When accurate hemodynamic assessment is important for clinical decision-making, V̇O2 should be directly measured. (Circulation. 2014;129:203-210.)
  8. Cardiac output (CO) is an important diagnostic and prognostic tool for patients with ventricular dysfunction. Pulmonary hypertension patients undergo invasive right heart catheterization to determine pulmonary vascular and cardiac hemodynamics. Thermodilution (TD) and direct Fick method are the most common methods of CO determination but are costly and may be associated with complications. The latest generation of impedance cardiography (ICG) provides noninvasive estimation of CO and is now validated. The purpose of this study was to compare ICG measurement of CO to TD and direct Fick in pulmonary hypertension patients. Thirty-nine enrolled patients were analyzed: 44% were male and average age was 50.8±17.4 years. Results for bias and precision of cardiac index were as follows: ICG vs. Fick (–0.13 L/min/m 2 and 0.46 L/min/m2), TD vs. Fick (0.10 L/min/m2 and 0.41 L/min/m2), ICG vs. TD (respectively, with a 95% level of agreement between –0.72 and 0.92 L/min/m2; CO correlation of ICG vs. Fick, TD vs. Fick, and ICG vs. TD was 0.84, 0.89, and 0.80, respectively). ICG provides an accurate, useful, and cost-effective method for determining CO in pulmonary hypertension patients, and is a potential tool for following responses to therapeutic interventions. (CHF. 2004;10(2 suppl 2):7–10)
  9. Background—Hemodynamic assessment after volume challenge has been proposed as a way to identify heart failure with preserved ejection fraction. However, the normal hemodynamic response to a volume challenge and how age and sex affect this relationship remain unknown. Methods and Results—Sixty healthy subjects underwent right heart catheterization to measure age- and sex-related normative responses of pulmonary capillary wedge pressure and mean pulmonary arterial pressure to volume loading with rapid saline infusion (100–200 mL/min). Hemodynamic responses to saline infusion in heart failure with preserved ejection fraction (n=11) were then compared with those of healthy young (<50 years of age) and older (≥50 years of age) subjects. In healthy subjects, pulmonary capillary wedge pressure increased from 10±2 to 16±3 mm Hg after ~1 L and to 20±3 mm Hg after ~2 L of saline infusion. Older women displayed a steeper increase in pulmonary capillary wedge pressure relative to volume infused (16±4 mm Hg·L−1·m2) than the other 3 groups (P≤0.019). Saline infusion resulted in a greater increase in mean pulmonary arterial pressure relative to cardiac output in women compared with men regardless of age. Subjects with heart failure with preserved ejection fraction exhibited a steeper increase in pulmonary capillary wedge pressure relative to infused volume (25±12 mm Hg·L−1·m2) than healthy young and older subjects (P≤0.005). Conclusions—Filling pressures rise significantly with volume loading, even in healthy volunteers. Older women and patients with heart failure with preserved ejection fraction exhibit the largest increases in pulmonary capillary wedge pressure and mean pulmonary arterial pressure. (Circulation. 2013;127:55-62.)
  10. Two nonblinded authors evaluated the validity of each of the four PAOP measurements by analyzing five preestablished criteria: (1) PAOP is less than the diastolic PAP, (2) the tracing is compatible with the atrial pressure waveform, (3) the fluoroscopic image demonstrates a stationary catheter after inflation, (4) free flow is present within the catheter, and (5) highly oxygenated blood (capillary) is obtained from the distal port while the catheter is in occlusion position.12 In every patient, we recorded the number of criteria present (one to five) in each of the four PAOP measurements. In addition, we identified in all patients the measurement with the highest number of criteria present that most likely reflected the LAP (namely, “best PAOP”) in order to assess for agreement in the PAOP measurements between left and right PAs with two different balloon inflation volumes. Background: Pulmonary artery occlusion pressure (PAOP) is used to differentiate patients with pulmonary hypertension (PH) associated with left-sided heart disease from other etiologies. Technical errors in the measurement of PAOP are common and lead to incorrect classification of the etiology of PH. We investigated the agreement among PAOP measurements obtained from both pulmonary arteries with balloon full (1.5 mL) and half (0.75 mL) inflation in patients undergoing right-sided heart catheterization for suspected PH. Methods: Thirty-seven patients suspected or known to have PH who underwent right-sided heart catheterization were included. Seventy-six percent had PH (mean pulmonary arterial pressure > 25 mm Hg). The validity of the measurements was assessed by using five preestablished criteria based on hemodynamic, fluoroscopic, and gasometric data. For each patient, the measurement that most likely represented the left atrial pressure was labeled “best PAOP.” Results: Seventy percent of all the PAOP measurements met at least four of the five preestablished criteria for validity. In patients with PH (n = 28), the mean ± SE PAOP was 23.1 ± 2 and 19.1 ± 2 mm Hg for balloon full and half inflation, respectively, in the right pulmonary artery and 23.54 ± 2 and 19.07 ± 2 mm Hg for balloon full and half inflation, respectively, in the left pulmonary artery (P = .05). Bland-Altman analysis revealed lower bias and narrower limits of agreement with balloon half inflation. Wedge angiography showed that some balloon inflations failed to occlude upstream flow, whereas others had collateral vessels draining after the occlusion. Conclusions: PAOP can be falsely elevated in patients with PH according to the balloon inflation volume. Balloon half inflation was safe and correlated with higher precision and lower bias in the PAOP measurements. Pulmonary hypertension (PH) is defined as a resting mean pulmonary arterial pressure (PAP) of ≥ 25 m